As a leader in drug discovery and diagnostic healthcare over the last two decades, Nevil has helped transform how drugs are tested and changed the direction of clinical trial design by using molecular imaging to save tens of millions of dollars for Big Pharma. In 2010, as CEO, he helped grow the largest private diagnostic clinic in Singapore with unmatched capabilities in nuclear medicine, successfully completing M&As with Fortis Healthcare in 2012 for USD56M and Fullerton Healthcare in 2014 for USD85M. Nevil’s technical expertise and entrepreneurial focus has helped raise over USD7M for startups. Supporting VCs to evaluate disruptive technologies using AI to accelerate disease diagnosis and drug discovery.
Subscribe To Our Newsletter
We respect your privacy. Your information is safe and will never be shared.